Skip to main content
. 2019 Aug 12;129(9):3827–3832. doi: 10.1172/JCI126185

Figure 3. Summary of fusion transcript expression, immunohistochemical results, and clinicopathological features of poroma and porocarcinoma.

Figure 3

Poroma (n = 104); porocarcinoma (n = 11). YAP1 immunohistochemistry (IHC) indicates cases with discordant expression of the N- and C-terminal regions.